Published on
According to a survey of 1,015 adults released by the National Foundation for Infectious Diseases (NFID), fewer adults are receiving vaccines for respiratory viruses this year. The study was conducted in November 2025 to evaluate adults’ attitudes and behaviors regarding vaccination for influenza, COVID-19, respiratory syncytial virus (RSV), and pneumococcal disease in the United States. NFID found that 45% of respondents said they have received at least 1 respiratory vaccine since September 2025, with influenza (34%) and COVID-19 (25%) vaccines showing the highest uptake. Fewer adults received pneumococcal (8%) and RSV (6%) vaccines, according to the survey. Historically, influenza vaccination coverage among adults was 48.4% in the 2019-2020 virus season, before the pandemic.
Seems to be the trend: Looking at year-over-year vaccine trends specifically in retail settings, IQVIA also found less vaccination uptake for RSV (-34%), COVID-19 (-27%), and influenza (-6%) for this respiratory virus season. However, it found a 27% increase in vaccines for pneumococcal disease. The rise is likely attributed to the now lower age threshold for pneumococcal vaccine eligibility (from 65 to 50 years), according to CIDRAP. In the NFID study, when asked to select one most-trusted source for vaccine information, 44% of adults cited healthcare professionals, and 13% cited the Centers for Disease Control and Prevention.